Which severe skin reactions have been reported with rituximab?

Toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome, some with fatal outcomes, have been reported with rituximab (MabThera); treatment should be permanently discontinued if such a reaction is suspected to be related to MabThera.